UnknownNot Applicable

Effects of the Combining Physical Exercise and Cognitive Training for the Community-based Elderly

Taiwan90 participantsStarted 2022-03-01

Plain-language summary

This study aims to (1) determine the intervention effects of sequential and simultaneous training on cognitive function and health-related function for cognitively-normal elderly and elderly with Mild Cognitive Impairment(MCI) and Subjective Cognitive Decline(SCD); (2) compare which combination approach is more advantageous for improvement on outcome measures.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. age≥60
. able to follow instruction
. MoCA\>26
. not SCD or MCI or Dementia

Exclusion criteria

. concomitant neurological conditions such as dementia, Parkinson's disease, brain tumor, brain injury and other brain diseases (such as intracranial hypertension or cerebral edema);
. have unstable cardiovascular status such as uncontrolled hypertension
. age\>=60

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change scores of the Montreal Cognitive Assessment (MoCA).

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Wechsler Memory Scale (WMS)

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Stroop test

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Color trials test

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Trial details

NCT IDNCT05225181

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

Contact for this trial

Ching-yi Wu, ScD

#886-3-2118800 cywu@mail.cgu.edu.tw

View on ClinicalTrials.gov More Cognitively-normal trials

Plain-language summary

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. age≥60
. able to follow instruction
. MoCA\>26
. not SCD or MCI or Dementia

Exclusion criteria

. concomitant neurological conditions such as dementia, Parkinson's disease, brain tumor, brain injury and other brain diseases (such as intracranial hypertension or cerebral edema);
. have unstable cardiovascular status such as uncontrolled hypertension
. age\>=60

What they're measuring

Change scores of the Montreal Cognitive Assessment (MoCA).

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Wechsler Memory Scale (WMS)

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Stroop test

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.

Change scores of Color trials test

Timeframe: baseline, after the intervention eight weeks, and at 3-month follow-up.